JnJ to acquire Halda Therapeutics for USD 3.05 Billion
Johnson & Johnson has signed a definitive agreement to acquire Halda Therapeutics OpCo, Inc., a clinical-stage biotech firm developing oral…
JnJ
Read More
March 4, 2026
- Six Lakh Babies Born with Birth Defects Annually; India Lacks National Tracking System
- India Rolls Out Free e-Sushrut@Clinic Platform to Digitise Small Healthcare Practices
- Iran War Puts Global and Indian Healthcare Business, Pharma Stocks on Edge
- Centre Extends Tenure of Rajeev Singh Raghuvanshi as DCGI Amid Ongoing Regulatory Reforms